SteelPeak Wealth LLC boosted its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 72.5% in the first quarter, HoldingsChannel reports. The firm owned 10,466 shares of the health services provider’s stock after acquiring an additional 4,398 shares during the period. SteelPeak Wealth LLC’s holdings in Cigna Group were worth $2,792,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of CI. Prosperity Consulting Group LLC boosted its stake in Cigna Group by 5.9% in the first quarter. Prosperity Consulting Group LLC now owns 2,705 shares of the health services provider’s stock worth $721,000 after purchasing an additional 151 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in shares of Cigna Group in the first quarter valued at $1,435,000. D.A. Davidson & CO. raised its holdings in shares of Cigna Group by 4.7% in the first quarter. D.A. Davidson & CO. now owns 18,842 shares of the health services provider’s stock valued at $5,026,000 after buying an additional 851 shares during the last quarter. Twin Capital Management Inc. lifted its position in Cigna Group by 6.9% during the 1st quarter. Twin Capital Management Inc. now owns 7,717 shares of the health services provider’s stock worth $2,059,000 after buying an additional 498 shares in the last quarter. Finally, Marks Group Wealth Management Inc lifted its position in Cigna Group by 72.3% during the 1st quarter. Marks Group Wealth Management Inc now owns 23,535 shares of the health services provider’s stock worth $6,278,000 after buying an additional 9,873 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Insider Buying and Selling
In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by company insiders.
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts expect that Cigna Group will post 30.39 EPS for the current year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.
Wall Street Analyst Weigh In
A number of brokerages have commented on CI. Wells Fargo & Company increased their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Royal Bank Of Canada increased their price target on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Finally, Raymond James Financial set a $340.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.
Read Our Latest Research Report on Cigna Group
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
